Andreia Barateiro
Overview
Explore the profile of Andreia Barateiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cillari R, Acurcio R, Barateiro A, Florindo H, Mauro N, Cavallaro G
J Control Release
. 2025 Mar;
381:113575.
PMID: 40024343
Fluorescent ultrasmall nanoparticles (d < 10 nm), such as carbon nanodots (CDs), are promising nanosystems for precision cancer therapy. Their optimal size allows them to diffuse within complex microenvironments, enabling...
2.
Sa A, Barateiro A, Bednarz B, Almeida P, Vaz P, Madaleno T
Front Oncol
. 2024 Aug;
14:1449082.
PMID: 39148904
[This corrects the article DOI: 10.3389/fonc.2022.879167.].
3.
da Silva I, Pimpao C, Paccetti-Alves I, Thomas S, Barateiro A, Casini A, et al.
J Physiol
. 2024 Feb;
602(13):3111-3129.
PMID: 38323926
Aquaporin-3 (AQP3) is a membrane channel with dual aquaglyceroporin/peroxiporin activity, facilitating the diffusion of water, glycerol and HO across cell membranes. AQP3 shows aberrant expression in melanoma and its role...
4.
Neto A, Fernandes A, Barateiro A
Front Cell Neurosci
. 2023 Nov;
17:1294420.
PMID: 38026693
Obesity is a global epidemic, affecting roughly 30% of the world's population and predicted to rise. This disease results from genetic, behavioral, societal, and environmental factors, leading to excessive fat...
5.
Sa A, Barateiro A, Bednarz B, Almeida P, Vaz P, Madaleno T
Front Oncol
. 2023 Oct;
13:1293922.
PMID: 37876973
[This corrects the article DOI: 10.3389/fonc.2022.879167.].
6.
Barateiro A, Barros C, Pinto M, Ribeiro A, Alberro A, Fernandes A
Front Mol Neurosci
. 2023 Feb;
16:1087745.
PMID: 36818652
History is full of women who made enormous contributions to science. While there is little to no imbalance at the early career stage, a decreasing proportion of women is found...
7.
Sa A, Barateiro A, Bednarz B, Almeida P, Vaz P, Madaleno T
Front Oncol
. 2022 Aug;
12:879167.
PMID: 35992845
Purpose: Out-of-field doses are given to healthy tissues, which may allow the development of second tumors. The use of IMRT in pediatric patients has been discussed, as it leads to...
8.
Acurcio R, Pozzi S, Carreira B, Pojo M, Gomez-Cebrian N, Casimiro S, et al.
J Immunother Cancer
. 2022 Jul;
10(7).
PMID: 35863821
Background: Inhibiting programmed cell death protein 1 (PD-1) or PD-ligand 1 (PD-L1) has shown exciting clinical outcomes in diverse human cancers. So far, only monoclonal antibodies are approved as PD-1/PD-L1...
9.
Barros C, Barateiro A, Neto A, Soromenho B, Basto A, Mateus J, et al.
Brain Commun
. 2022 May;
4(3):fcac076.
PMID: 35620168
Studies have correlated excessive S100B, a small inflammatory molecule, with demyelination and associated inflammatory processes occurring in multiple sclerosis. The relevance of S100B in multiple sclerosis pathology brought an emerging...
10.
Ribeiro A, Barros C, Barateiro A, Howlett S, Fernandes A
J Gerontol A Biol Sci Med Sci
. 2021 Jun;
77(1):1-9.
PMID: 34181005
The experimental autoimmune encephalomyelitis (EAE) model is the most commonly used animal model of multiple sclerosis (MS). However, phenotypic characterization of mice based on the traditional 5-point clinical paralysis scale...